Quantinno Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.9M Buy
28,037
+5,814
+26% +$1.17M 0.01% 1340
2026
Q2
$4.23M Buy
22,223
+2,331
+12% +$401K 0.01% 1389
2026
Q1
$3.36M Buy
19,892
+4,939
+33% +$845K 0.01% 1328
2025
Q4
$2.52M Buy
14,953
+8,871
+146% +$1.44M 0.01% 1284
2025
Q3
$878K Buy
6,082
+1,764
+41% +$241K ﹤0.01% 1570
2025
Q2
$546K Buy
4,318
+2,454
+132% +$301K ﹤0.01% 1598
2025
Q1
$238K Buy
+1,864
New +$253K ﹤0.01% 1756
2024
Q4
– Sell
-1,679
Closed -$244K – 1661
2024
Q3
$244K Buy
+1,679
New +$243K ﹤0.01% 1333

Other funds holding IBB

Quantinno Capital Management's IBB Position: Q3 2026 in Review

Quantinno Capital Management increased its iShares Biotechnology ETF (IBB) stake by 26% in Q3 2026, buying an estimated $1.17M and bringing the position to 28,037 shares worth $5.9M. The position accounts for 0.01% of the portfolio, ranked #1340.

Quantinno Capital Management first reported a position in IBB in Q3 2024 and has held it in 8 quarters since. 1,029 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Quantinno Capital Management held 28,037 shares of iShares Biotechnology ETF worth $5.9M as of Q3 2026.
  • Quantinno Capital Management bought 5,814 iShares Biotechnology ETF shares in Q3 2026, an estimated $1.17M.
  • iShares Biotechnology ETF made up 0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1340 holding.
  • Quantinno Capital Management first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 8 quarters since.
  • 1,029 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.